Influenza vaccine live-attenuated - Polymun Scientific

Drug Profile

Influenza vaccine live-attenuated - Polymun Scientific

Alternative Names: Vero-Vac

Latest Information Update: 22 Apr 2016

Price : $50

At a glance

  • Originator Polymun Scientific
  • Class Influenza virus vaccines-live; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No
  • Available For Licensing Yes - Influenza virus infections

Highest Development Phases

  • Phase I Influenza virus infections

Most Recent Events

  • 22 Apr 2016 Phase-I clinical trials in Influenza virus infections (Prevention) in Russia (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top